Amyloid cast nephropathy: A rare presentation of multiple myeloma

Abstract

Introduction:

Monoclonal immunoglobulins can cause a variety of histologic patterns of kidney injury, depending on the physicochemical properties. Multiple myeloma manifests more often as light-chain nephropathy. On the other hand, light-chain amyloidosis leads to glomerular and vascular amyloid deposits, but a less common presentation with amyloid casts has also been described. Rarely, more than one histologic pattern can be present in the same patient.

Case report:

We report a case of a 73-year-old man, diagnosed with multiple myeloma that 8 months after achieving partial response to chemotherapy develops acute kidney injury and nephrotic syndrome. Kidney biopsy revealed features of light-chain nephropathy, amyloid cast nephropathy, and glomerular and vascular amyloid deposits. Immunofluorescence was positive for IgA (++) and lambda chains (+++) and negative for kappa chains. After the diagnosis of multiple myeloma-associated light-chain amyloidosis, chemotherapy was initiated; unfortunately, the patient died 1 month after the diagnosis.

Conclusion:

Amyloid casts, isolated or accompanied by other renal or extra-renal amyloid deposits, are another form of tubular toxicity caused by dysproteinemias and should be systematically screened in kidney biopsies.

Keywords

Amyloidosis multiple myeloma amyloid casts

Get full access to this article

View all access options for this article.

References

Dimopoulos

Moreau

Terpos

, et al. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021; 32(3): 309–322.

Chang

Thamboo

Choong

CSH

, et al. Multiple myeloma-associated light chain amyloidosis and a proposed approach to monoclonal immunoglobulin-associated renal disease. Case Rep Nephrol Dial 2020; 10(3): 95–103.

Leung

Bridoux

Batuman

, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol 2019; 15(1): 45–59.

Gibier

Gnemmi

Glowacki

, et al. Intratubular amyloid in light chain cast nephropathy is a risk factor for systemic light chain amyloidosis. Mod Pathol 2018; 31(3): 452–462.

Sethi

Hanna

Fervenza

. Unusual casts in a case of multiple myeloma. Am J Kidney Dis 2009; 54(5): 970–974.

Kato

Fujigaki

Asakawa

, et al. Rapid deterioration of the renal function caused by the coexistence of intratubular amyloidosis and myeloma cast nephropathy. Intern Med 2015; 54(23): 3023–3028.

Kurien

Fernando

. Amyloid proximal tubulopathy and amyloid casts: an unusual finding in multiple myeloma. Indian J Nephrol 2018; 28(2): 160–163.

Mizuno

Kosukegawa

. Amyloid cast nephropathy with systemic AL amyloidosis. Int J Hematol 2021; 113(1): 1–2.

Yong

Lin

, et al. Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report. BMC Nephrol 2021; 22(1): 6.

10.

Pardanani

Witzig

Schroeder

, et al. Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis. Blood 2003; 101(3): 827–830.

Amyloid cast nephropathy: A rare presentation of multiple myeloma–associated light chain amyloidosis